Your session is about to expire
← Back to Search
Contrast-Enhanced Ultrasound for Wounds and Injuries
Study Summary
This trial is looking at using ultrasound with contrast to see if it can be used to detect abdominal injuries in children under 8 years old.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not need emergency surgery within the next hour.I have had or will have an abdominal CT scan.I have a known heart condition from birth or acquired later.I am allergic to Lumason or its ingredients.I am younger than 8 years old.
- Group 1: Prospective Observation
- Group 2: Contrast-Enhanced Ultrasound using Lumason
- Group 3: Retrospective Review
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this therapy been accepted by the Food and Drug Administration?
"After extensive review, our team has determined that this treatment option is approved and thus merits a safety rating of 3."
Are senior citizens welcome to participate in this clinical endeavor?
"This clinical trial seeks out patients who range in age from infancy up to 7 years old."
Has this type of research been conducted before?
"Presently, 14 trials for this drug are in progress and span 9 urban centres across 2 nations. The initial trial occurred back in 2017 when Bracco Diagnostics, Inc ran a Phase < 1 clinical study with 125 participants. Since then, 25 more studies have concluded successfully."
Have there been other examinations of this treatment's efficacy?
"Currently, 14 active clinical trials are researching this treatment. Of these studies, 3 have made it to Phase 3. Philadelphia, Pennsylvania is one of the leading locations for testing this medication with 18 different medical sites recruiting patients."
How many participants is the clinical trial currently accommodating?
"Recruitment for this clinical trial has ended. Initially posted on May 9th 2018 and last updated on January 3rd 2023, it is no longer enrolling patients. If you are seeking other studies, 822 trials with abdominal injuries and 14 studies regarding the specified treatment are currently recruiting participants."
To whom is this clinical investigation accessible?
"The criteria for this study necessitates that subjects have abdominal traumas and are between 0 to 7 years old. A total of 120 individuals must be enrolled in the trial."
Is this clinical research currently accepting volunteers?
"As detailed on clinicaltrials.gov, this medical research is no longer recruiting patients; the trial was first posted in May 2018 and last updated in January 2023. Fortunately, there are 836 other experiments that are actively accepting participants at the present time."
Share this study with friends
Copy Link
Messenger